Skip to main content
Premium Trial:

Request an Annual Quote

JMS Realty Trust, B&H Group Limited, NAI Hunneman Commercial, 9 Centennial Drive, 10 Technology Drive

Sale of Two Peabody, Mass., Buildings Fetches $12.1M for JMS Realty Trust
Two Peabody, Mass., buildings suitable for R&D use have been sold by James Salah’s JMS Realty Trust of Dedham, Mass., to B&H Group Limited for $12.1 million, in a deal announced by the commercial real estate brokerage involved in the sale.
NAI Hunneman Commercial represented JMS in the sale of the buildings, which total 126,801 square feet. Acquired by B&H were 9 Centennial Drive, a two-story, 75,000 square-foot office building suitable for office or R&D use; and 10 Technology Drive, a single-story, 51,000 square-foot office/warehouse building also suitable for R&D use. Both buildings are within the 307-acre, 45-building Centennial Park, developed in the 1980s by the Peabody Community Development Authority and located off Route 128.
10 Technology Drive was completed in 1980 and 9 Centennial Drive, six years later.
Four NAI Hunneman professionals represented JMS: Peter Benke, executive vice president; David Ross, executive vice president/principal; Dan McGee, financial analyst; and Jeffrey Becker senior vice president. B&H represented itself in the transaction.

The Scan

Germline-Targeting HIV Vaccine Shows Promise in Phase I Trial

A National Institutes of Health-led team reports in Science that a broadly neutralizing antibody HIV vaccine induced bnAb precursors in 97 percent of those given the vaccine.

Study Uncovers Genetic Mutation in Childhood Glaucoma

A study in the Journal of Clinical Investigation ties a heterozygous missense variant in thrombospondin 1 to childhood glaucoma.

Gene Co-Expression Database for Humans, Model Organisms Gets Update

GeneFriends has been updated to include gene and transcript co-expression networks based on RNA-seq data from 46,475 human and 34,322 mouse samples, a new paper in Nucleic Acids Research says.

New Study Investigates Genomics of Fanconi Anemia Repair Pathway in Cancer

A Rockefeller University team reports in Nature that FA repair deficiency leads to structural variants that can contribute to genomic instability.